Literature DB >> 27248844

Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutation.

Christina D Drenberg1,2, Daelynn R Buelow1,2, Stanley B Pounds3, Yong-Dong Wang4, David Finkelstein4, Richard J Rahija5, Sheila A Shurtleff6, Jeffrey E Rubnitz6, Hiroto Inaba6, Tanja A Gruber6, Jeffery M Klco7, Sharyn D Baker1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27248844      PMCID: PMC5102776          DOI: 10.1080/10428194.2016.1187272

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  14 in total

1.  The most informative spacing test effectively discovers biologically relevant outliers or multiple modes in expression.

Authors:  Iwona Pawlikowska; Gang Wu; Michael Edmonson; Zhifa Liu; Tanja Gruber; Jinghui Zhang; Stan Pounds
Journal:  Bioinformatics       Date:  2014-01-22       Impact factor: 6.937

2.  Clinical implications of FLT3 mutations in pediatric AML.

Authors:  Soheil Meshinchi; Todd A Alonzo; Derek L Stirewalt; Michel Zwaan; Martin Zimmerman; Dirk Reinhardt; Gertjan J L Kaspers; Nyla A Heerema; Robert Gerbing; Beverly J Lange; Jerald P Radich
Journal:  Blood       Date:  2006-08-15       Impact factor: 22.113

3.  Functional heterogeneity of genetically defined subclones in acute myeloid leukemia.

Authors:  Jeffery M Klco; David H Spencer; Christopher A Miller; Malachi Griffith; Tamara L Lamprecht; Michelle O'Laughlin; Catrina Fronick; Vincent Magrini; Ryan T Demeter; Robert S Fulton; William C Eades; Daniel C Link; Timothy A Graubert; Matthew J Walter; Elaine R Mardis; John F Dipersio; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-06       Impact factor: 31.743

Review 4.  Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia.

Authors:  R Swords; C Freeman; F Giles
Journal:  Leukemia       Date:  2012-04-27       Impact factor: 11.528

5.  Expression and prognostic impact of lncRNAs in acute myeloid leukemia.

Authors:  Ramiro Garzon; Stefano Volinia; Dimitrios Papaioannou; Deedra Nicolet; Jessica Kohlschmidt; Pearlly S Yan; Krzysztof Mrózek; Donna Bucci; Andrew J Carroll; Maria R Baer; Meir Wetzler; Thomas H Carter; Bayard L Powell; Jonathan E Kolitz; Joseph O Moore; Ann-Kathrin Eisfeld; James S Blachly; William Blum; Michael A Caligiuri; Richard M Stone; Guido Marcucci; Carlo M Croce; John C Byrd; Clara D Bloomfield
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

6.  Human AML cells in NOD/SCID mice: engraftment potential and gene expression.

Authors:  R Lumkul; N-C Gorin; M T Malehorn; G T Hoehn; R Zheng; B Baldwin; D Small; S Gore; D Smith; P S Meltzer; C I Civin
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

7.  A robust xenotransplantation model for acute myeloid leukemia.

Authors:  P V Sanchez; R L Perry; J E Sarry; A E Perl; K Murphy; C R Swider; A Bagg; J K Choi; J A Biegel; G Danet-Desnoyers; M Carroll
Journal:  Leukemia       Date:  2009-07-23       Impact factor: 11.528

8.  Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemia.

Authors:  Sharyn D Baker; Eric I Zimmerman; Yong-Dong Wang; Shelley Orwick; Douglas S Zatechka; Jassada Buaboonnam; Geoffrey A Neale; Scott R Olsen; Eric J Enemark; Sheila Shurtleff; Jeffrey E Rubnitz; Charles G Mullighan; Hiroto Inaba
Journal:  Clin Cancer Res       Date:  2013-08-22       Impact factor: 12.531

9.  The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression.

Authors:  Thomas Derrien; Rory Johnson; Giovanni Bussotti; Andrea Tanzer; Sarah Djebali; Hagen Tilgner; Gregory Guernec; David Martin; Angelika Merkel; David G Knowles; Julien Lagarde; Lavanya Veeravalli; Xiaoan Ruan; Yijun Ruan; Timo Lassmann; Piero Carninci; James B Brown; Leonard Lipovich; Jose M Gonzalez; Mark Thomas; Carrie A Davis; Ramin Shiekhattar; Thomas R Gingeras; Tim J Hubbard; Cedric Notredame; Jennifer Harrow; Roderic Guigó
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

10.  Human genes and pseudogenes for the 7SL RNA component of signal recognition particle.

Authors:  E Ullu; A M Weiner
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

View more
  2 in total

1.  Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia.

Authors:  Jolieke G van Oosterwijk; Daelynn R Buelow; Christina D Drenberg; Aksana Vasilyeva; Lie Li; Lei Shi; Yong-Dong Wang; David Finkelstein; Sheila A Shurtleff; Laura J Janke; Stanley Pounds; Jeffrey E Rubnitz; Hiroto Inaba; Navjotsingh Pabla; Sharyn D Baker
Journal:  J Clin Invest       Date:  2017-12-11       Impact factor: 14.808

2.  An unexpected protein interaction promotes drug resistance in leukemia.

Authors:  Aaron Pitre; Yubin Ge; Wenwei Lin; Yao Wang; Yu Fukuda; Jamshid Temirov; Aaron H Phillips; Jennifer L Peters; Yiping Fan; Jing Ma; Amanda Nourse; Chandrima Sinha; Hai Lin; Richard Kriwacki; James R Downing; Tanja A Gruber; Victoria E Centonze; Anjaparavanda P Naren; Taosheng Chen; John D Schuetz
Journal:  Nat Commun       Date:  2017-11-16       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.